SIETES :: 92854 citas

Resultados de la búsqueda por VÍA TRANSDÉRMICA REFINAR BÚSQUEDA

1.

Hider-Mlynarz K, Cavalié P, Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102806]

2.

Eiden C, Mathieu O, Donnadieu-Rigole H, Marrot C, Peyrière H. High opioids tolerance due to transmucosal fentanyl abuse. Eur J Clin Pharmacol 2017;73:1195-6. [Ref.ID 102078]

3.

Anónimo. Capsaïcine et douleurs neuropathiques diabétiques. Prescrire 2016;36:734-6. [Ref.ID 100890]

4.

Anonimo. Zecuity (sumatriptan) migraine patch: Drug Safety Communication - FDA evaluating risk of burns and scars. FDA MedWatch alert 2016:2 de junio. [Ref.ID 100411]

5.

Anónimo. Zecuity (sumatriptan) migraine patch: Drug Safety Communication - FDA evaluating risk of burns and scars. U.S. Food and Drug Administration 2016:2 de junio. [Ref.ID 100357]

6.

Shaheed CA, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med 2016;176:958-68. [Ref.ID 100298]

7.

Anónimo. Éthinylestradiol + gestodène. Prescrire 2015;35:647-8. [Ref.ID 99707]

8.

Stam-Slob MC, Lambalk CB, van de Ree MA. Contraceptive and hormonal treatment options for women with history of venous thromboembolism. BMJ 2015;351:h4847. [Ref.ID 99595]

9.

Anónimo. Rotigotine transdermique dans les jambes sans repos: troubles compulsifs. Prescrire 2014;34:351. [Ref.ID 97561]

10.

Anónimo. Low-dose diclofenac (Zorvolex) for pain. Med Lett Drugs Ther 2014;56:19-20. [Ref.ID 97421]

11.

Bateson D, McNamee K, Briggs P. Newer non-oral hormonal contraception. BMJ 2013;346:35-9. [Ref.ID 95367]

12.

Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception 2013;87:93-100. [Ref.ID 94618]

13.

Petitti DB. Hormonal contraceptives and arterial thrombosis - Not risk-free but safe enough. N Engl J Med 2012;366:2316-8. [Ref.ID 93214]

14.

Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366:2257-66. [Ref.ID 93210]

15.

Anónimo. Transdermal buprenorphine (Butrans) for chronic pain. Med Lett Drugs Ther 2011;53:31-2. [Ref.ID 90668]

16.

Swerdloff RS, Wang C. Dihydrotestosterone: hormone or autocrine-paracrine signal?. Ann Intern Med 2010;153:678-9. [Ref.ID 89658]

17.

Idan A, Griffiths KA, Harwood DT, Seibel MJ, Turner L, Conway AJ, Handelsman DJ. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease. A randomized, placebo-controlled trial. Ann Intern Med 2010;153:621-32. [Ref.ID 89656]

18.

Miselli M. Ossibutinina transdermica. Informazioni sui Farmaci 2010;34:47-8. [Ref.ID 89058]

19.

Renoux C, Dell'Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;341:83. [Ref.ID 88872]

20.

Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault M-C, Clavel-Chapelon F, Scarabin PY. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort Study. Artherioscler Thromb Vasc Biol 2010;30:340-5. [Ref.ID 88483]